v3.25.4
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Summary of Option Activity
A summary of option activity under our Equity Incentive Plans as of December 31, 2025, and changes during the year ended December 31, 2025, is as follows:
Number of
shares		Weighted-
average
exercise price
per share		Weighted-
average
remaining
contractual
term
(in years)		Aggregate
intrinsic
value
(in thousands)
Outstanding at January 1, 202518,048,109$1.82 6.1$19,839 
Granted—$— —— 
Exercised(4,674,357)$1.09 —— 
Expired / forfeited(321,801)$2.18 —— 
Outstanding at December 31, 202513,051,951$2.07 5.7$76,006 
Vested and exercisable at December 31, 202512,600,574$2.04 5.7$73,624 
Vested and expected to vest at December 31, 202513,051,951$2.07 5.7$76,006 
Summary of RSU Activity
A summary of RSU activity under our Equity Incentive Plans as of December 31, 2025, and changes during the year ended December 31, 2025, is as follows:
Number of
shares		Weighted-average
grant date fair value
Outstanding at January 1, 20254,311,271$2.74 
Granted3,598,402$3.81 
Vested(2,021,697)$2.47 
Forfeited(672,321)$3.40 
Outstanding at December 31, 20255,215,655$3.49 
Summary of Outstanding Stock Warrants
Shown below is a summary of the activity of the stock warrants as of and during the year ended December 31, 2025:
Public
warrants		Private
warrants		PIPE
warrants		Total
Outstanding, December 31, 202416,692,572 300,000 2,052,500 19,045,072 
Exercise of stock warrants(200,100)— — (200,100)
Outstanding, December 31, 202516,492,472 300,000 2,052,500 18,844,972 
Summary of Stock-Based Compensation Expense
Stock-based compensation from stock options and RSUs under our Equity Incentive Plans were included in the following lines in the accompanying consolidated statements of operations during the periods presented (in thousands):
Year ended December 31,
20252024
Cost of revenue$633 $871 
Research and development1,246 936 
Selling, general and administrative5,531 5,536 
Total stock-based compensation expense$7,410 $7,343